United States Biotechnology & Medical Research

Nurix Therapeutics, Inc. (NRIX)

Track

Track

Nurix Therapeutics experienced nineteen insider transactions over the past ninety days, all representing sales. Executives offloaded shares worth approximately 2.37 million dollars. These divestments occurred following a recent earnings report that missed expectations. The stock price remains down 4.4 percent during this period, despite trading near the upper end of its yearly range.
Ticker: NRIX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nurix Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
57.62
Quantity 78,730 +11.7%
Value US$1,358,736
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
57.16
Quantity 62,542
Value US$934,659
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
455.72
Quantity 59,021 -38.2%
Value US$3,251,606
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
25.69
Quantity 5,387 -36.2%
Value US$138,417
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
26.04
Quantity 5,787
Value US$150,693
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.47
Quantity 1,452 -1.2%
Value US$36,982
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 4,356 -3.6%
Value US$108,900
2.9
GWENN HANSEN Officer Officer
Transaction date
Proposed sale
Price
24.69
Quantity 8,712
Value US$215,099
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
24.64
Quantity 2,611 -2.2%
Value US$64,339
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
23.87
Quantity 1,500 -1.2%
Value US$35,803
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.65
Quantity 2,967 -6.9%
Value US$73,129
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
23.89
Quantity 1,794 -4.0%
Value US$42,861
2.9
GWENN M HANSEN Officer Officer
Transaction date
Proposed sale
Price
23.22
Quantity 4,111
Value US$95,457
3.0
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
23.22
Quantity 4,761
Value US$110,550
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
23.05
Quantity 16,589 -64.6%
Value US$382,358
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
23.21
Quantity 16,589
Value US$385,031
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
23.38
Quantity 2,845 -6.0%
Value US$66,524
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
23.38
Quantity 3,847 -16.2%
Value US$89,954
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
23.38
Quantity 3,847 -3.1%
Value US$89,954
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
23.56
Quantity 11,008 -44.8%
Value US$259,366
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
23.91
Quantity 11,008
Value US$263,201
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 5,394 -4.5%
Value US$107,880
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
20.06
Quantity 28,935 -68.1%
Value US$580,506
2.9
GWENN M HANSEN Officer Officer
Transaction date
Proposed sale
Price
19.30
Quantity 5,394
Value US$104,104
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
19.30
Quantity 28,935
Value US$558,446
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.60
Quantity 8,148 -37.5%
Value US$135,253
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
17.39
Quantity 8,148
Value US$141,694
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.18
Quantity 582 -1.5%
Value US$9,996
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
16.58
Quantity 13,473 -26.1%
Value US$223,323
3.0
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
16.93
Quantity 14,055
Value US$237,951
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.96
Quantity 8,148 -30.8%
Value US$138,210
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.81
Quantity 8,148
Value US$136,968
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.76
Quantity 5,394 -16.9%
Value US$90,407
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.70
Quantity 5,394
Value US$90,080
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
16.65
Quantity 2,388 -4.4%
Value US$39,749
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
16.65
Quantity 3,214 -2.6%
Value US$53,498
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
16.65
Quantity 3,214 -9.2%
Value US$53,498
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
15.24
Quantity 8,148 -23.5%
Value US$124,149
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
15.48
Quantity 8,148
Value US$126,131
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
15.44
Quantity 8,148 -19.1%
Value US$125,793
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
15.97
Quantity 8,148
Value US$130,124
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.66
Quantity 14,261 -25.0%
Value US$237,618
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.85
Quantity 14,261
Value US$240,298
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
17.37
Quantity 73 -0.2%
Value US$1,268
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
16.58
Quantity 3,588 -7.3%
Value US$59,498
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
17.37
Quantity 98 -0.1%
Value US$1,702
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
16.58
Quantity 4,797 -5.4%
Value US$79,547
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
17.37
Quantity 88 -0.2%
Value US$1,529
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
16.58
Quantity 4,333 -7.1%
Value US$71,852
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.42
Quantity 3,760 -6.9%
Value US$69,273
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
18.21
Quantity 7,520
Value US$136,939
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.56
Quantity 200 -0.4%
Value US$3,711
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
17.87
Quantity 3,560 -6.5%
Value US$63,603
3.0
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.76
Quantity 37,600
Value US$630,176
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
17.07
Quantity 37,600 -42.5%
Value US$641,697
3.0
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
12.94
Quantity 6,284
Value US$81,315
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.56
Quantity 6,284 -14.3%
Value US$78,931
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
12.80
Quantity 3,130 -6.7%
Value US$40,054
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
12.80
Quantity 4,087 -5.1%
Value US$52,300
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
12.80
Quantity 3,644 -6.7%
Value US$46,631
3.0
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
11.26
Quantity 5,402
Value US$60,827
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.03
Quantity 5,402 -13.2%
Value US$59,598
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
12.01
Quantity 4,304 -9.5%
Value US$51,695
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
12.01
Quantity 3,841 -8.0%
Value US$46,134
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
12.01
Quantity 4,308 -5.9%
Value US$51,743
3.0
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
11.16
Quantity 6,198
Value US$69,170
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.33
Quantity 6,198 -15.5%
Value US$70,243
2.9
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
11.50
Quantity 3,377 -5.2%
Value US$38,841
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
11.50
Quantity 2,438 -5.8%
Value US$28,041
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
11.50
Quantity 2,894 -7.2%
Value US$33,286
3.0
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
15.45
Quantity 5,825
Value US$89,996
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.13
Quantity 700 -2.0%
Value US$10,591
3.0
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.40
Quantity 5,125 -13.0%
Value US$73,797
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
20.48
Quantity 100 -0.3%
Value US$2,048
3.0
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
19.94
Quantity 5,660 -14.8%
Value US$112,886
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-10-02 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
78,730 +11.7%
57.62
US$1,358,736 		78,730 +11.7% 57.62 US$1,358,736
2026-10-02 2026-10-02 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
62,542
57.16
US$934,659 		62,542 57.16 US$934,659
2026-09-02 2026-09-02 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
59,021 -38.2%
455.72
US$3,251,606 		59,021 -38.2% 455.72 US$3,251,606
2026-09-02 2026-09-02 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
5,387 -36.2%
25.69
US$138,417 		5,387 -36.2% 25.69 US$138,417
2026-09-02 2026-09-02 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
5,787
26.04
US$150,693 		5,787 26.04 US$150,693
2026-09-01 2026-09-01 PlS Planned sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
1,452 -1.2%
25.47
US$36,982 		1,452 -1.2% 25.47 US$36,982
2026-08-05 2026-08-05 PlS Planned sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
4,356 -3.6%
25.00
US$108,900 		4,356 -3.6% 25.00 US$108,900
2026-08-05 2026-08-05 PrS Proposed sale
2.9
GWENN HANSEN

Officer

Officer
8,712
24.69
US$215,099 		8,712 24.69 US$215,099
2026-08-05 2026-08-04 PlS Planned sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
2,611 -2.2%
24.64
US$64,339 		2,611 -2.2% 24.64 US$64,339
2026-08-05 2026-08-04 PlS Planned sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
1,500 -1.2%
23.87
US$35,803 		1,500 -1.2% 23.87 US$35,803
2026-08-04 2026-08-04 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
2,967 -6.9%
24.65
US$73,129 		2,967 -6.9% 24.65 US$73,129
2026-08-04 2026-08-04 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
1,794 -4.0%
23.89
US$42,861 		1,794 -4.0% 23.89 US$42,861
2026-08-04 2026-08-04 PrS Proposed sale
2.9
GWENN M HANSEN

Officer

Officer
4,111
23.22
US$95,457 		4,111 23.22 US$95,457
2026-08-04 2026-08-04 PrS Proposed sale
3.0
JOHANNES VAN HOUTE

Officer

Officer
4,761
23.22
US$110,550 		4,761 23.22 US$110,550
2026-08-03 2026-08-03 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
16,589 -64.6%
23.05
US$382,358 		16,589 -64.6% 23.05 US$382,358
2026-08-03 2026-08-03 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
16,589
23.21
US$385,031 		16,589 23.21 US$385,031
2026-07-30 2026-07-30 S Sale
3.0
van Houte Hans

Chief Financial Officer

Officer
2,845 -6.0%
23.38
US$66,524 		2,845 -6.0% 23.38 US$66,524
2026-07-30 2026-07-30 S Sale
3.0
Ring Christine

Chief Legal Officer

Officer
3,847 -16.2%
23.38
US$89,954 		3,847 -16.2% 23.38 US$89,954
2026-07-30 2026-07-30 S Sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
3,847 -3.1%
23.38
US$89,954 		3,847 -3.1% 23.38 US$89,954
2026-07-02 2026-07-02 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
11,008 -44.8%
23.56
US$259,366 		11,008 -44.8% 23.56 US$259,366
2026-07-02 2026-07-02 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
11,008
23.91
US$263,201 		11,008 23.91 US$263,201
2026-06-25 2026-06-25 PlS Planned sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
5,394 -4.5%
20.00
US$107,880 		5,394 -4.5% 20.00 US$107,880
2026-06-25 2026-06-25 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
28,935 -68.1%
20.06
US$580,506 		28,935 -68.1% 20.06 US$580,506
2026-06-25 2026-06-25 PrS Proposed sale
2.9
GWENN M HANSEN

Officer

Officer
5,394
19.30
US$104,104 		5,394 19.30 US$104,104
2026-06-25 2026-06-25 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
28,935
19.30
US$558,446 		28,935 19.30 US$558,446
2026-06-02 2026-06-02 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
8,148 -37.5%
16.60
US$135,253 		8,148 -37.5% 16.60 US$135,253
2026-06-02 2026-06-02 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
8,148
17.39
US$141,694 		8,148 17.39 US$141,694
2026-05-05 2026-05-05 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
582 -1.5%
17.18
US$9,996 		582 -1.5% 17.18 US$9,996
2026-05-05 2026-05-05 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
13,473 -26.1%
16.58
US$223,323 		13,473 -26.1% 16.58 US$223,323
2026-05-05 2026-05-05 PrS Proposed sale
3.0
JOHANNES VAN HOUTE

Officer

Officer
14,055
16.93
US$237,951 		14,055 16.93 US$237,951
2026-05-04 2026-05-04 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
8,148 -30.8%
16.96
US$138,210 		8,148 -30.8% 16.96 US$138,210
2026-05-04 2026-05-04 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
8,148
16.81
US$136,968 		8,148 16.81 US$136,968
2026-05-01 2026-05-01 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
5,394 -16.9%
16.76
US$90,407 		5,394 -16.9% 16.76 US$90,407
2026-05-01 2026-05-01 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
5,394
16.70
US$90,080 		5,394 16.70 US$90,080
2026-04-30 2026-04-30 S Sale
3.0
van Houte Hans

Chief Financial Officer

Officer
2,388 -4.4%
16.65
US$39,749 		2,388 -4.4% 16.65 US$39,749
2026-04-30 2026-04-30 S Sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
3,214 -2.6%
16.65
US$53,498 		3,214 -2.6% 16.65 US$53,498
2026-04-30 2026-04-30 S Sale
3.0
Ring Christine

Chief Legal Officer

Officer
3,214 -9.2%
16.65
US$53,498 		3,214 -9.2% 16.65 US$53,498
2026-04-02 2026-04-02 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
8,148 -23.5%
15.24
US$124,149 		8,148 -23.5% 15.24 US$124,149
2026-04-02 2026-04-02 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
8,148
15.48
US$126,131 		8,148 15.48 US$126,131
2026-03-02 2026-03-02 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
8,148 -19.1%
15.44
US$125,793 		8,148 -19.1% 15.44 US$125,793
2026-03-02 2026-03-02 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
8,148
15.97
US$130,124 		8,148 15.97 US$130,124
2026-02-09 2026-02-09 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
14,261 -25.0%
16.66
US$237,618 		14,261 -25.0% 16.66 US$237,618
2026-02-09 2026-02-09 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
14,261
16.85
US$240,298 		14,261 16.85 US$240,298
2026-01-30 2026-01-30 S Sale
3.0
van Houte Hans

Chief Financial Officer

Officer
73 -0.2%
17.37
US$1,268 		73 -0.2% 17.37 US$1,268
2026-01-30 2026-01-30 S Sale
3.0
van Houte Hans

Chief Financial Officer

Officer
3,588 -7.3%
16.58
US$59,498 		3,588 -7.3% 16.58 US$59,498
2026-01-30 2026-01-30 S Sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
98 -0.1%
17.37
US$1,702 		98 -0.1% 17.37 US$1,702
2026-01-30 2026-01-30 S Sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
4,797 -5.4%
16.58
US$79,547 		4,797 -5.4% 16.58 US$79,547
2026-01-30 2026-01-30 S Sale
3.0
Ring Christine

Chief Legal Officer

Officer
88 -0.2%
17.37
US$1,529 		88 -0.2% 17.37 US$1,529
2026-01-30 2026-01-30 S Sale
3.0
Ring Christine

Chief Legal Officer

Officer
4,333 -7.1%
16.58
US$71,852 		4,333 -7.1% 16.58 US$71,852
2026-01-20 2026-01-20 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
3,760 -6.9%
18.42
US$69,273 		3,760 -6.9% 18.42 US$69,273
2025-12-18 2025-12-18 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
7,520
18.21
US$136,939 		7,520 18.21 US$136,939
2025-12-18 2025-12-18 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
200 -0.4%
18.56
US$3,711 		200 -0.4% 18.56 US$3,711
2025-12-18 2025-12-18 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
3,560 -6.5%
17.87
US$63,603 		3,560 -6.5% 17.87 US$63,603
2025-11-24 2025-11-24 PrS Proposed sale
3.0
CHRISTINE RING

Officer

Officer
37,600
16.76
US$630,176 		37,600 16.76 US$630,176
2025-11-24 2025-11-24 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
37,600 -42.5%
17.07
US$641,697 		37,600 -42.5% 17.07 US$641,697
2025-11-03 2025-11-03 PrS Proposed sale
3.0
JOHANNES VAN HOUTE

Officer

Officer
6,284
12.94
US$81,315 		6,284 12.94 US$81,315
2025-11-03 2025-11-03 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
6,284 -14.3%
12.56
US$78,931 		6,284 -14.3% 12.56 US$78,931
2025-10-30 2025-10-30 S Sale
3.0
van Houte Hans

Chief Financial Officer

Officer
3,130 -6.7%
12.80
US$40,054 		3,130 -6.7% 12.80 US$40,054
2025-10-30 2025-10-30 S Sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
4,087 -5.1%
12.80
US$52,300 		4,087 -5.1% 12.80 US$52,300
2025-10-30 2025-10-30 S Sale
3.0
Ring Christine

Chief Legal Officer

Officer
3,644 -6.7%
12.80
US$46,631 		3,644 -6.7% 12.80 US$46,631
2025-08-01 2025-08-01 PrS Proposed sale
3.0
JOHANNES VAN HOUTE

Officer

Officer
5,402
11.26
US$60,827 		5,402 11.26 US$60,827
2025-08-01 2025-08-01 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
5,402 -13.2%
11.03
US$59,598 		5,402 -13.2% 11.03 US$59,598
2025-07-30 2025-07-30 S Sale
3.0
van Houte Hans

Chief Financial Officer

Officer
4,304 -9.5%
12.01
US$51,695 		4,304 -9.5% 12.01 US$51,695
2025-07-30 2025-07-30 S Sale
3.0
Ring Christine

Chief Legal Officer

Officer
3,841 -8.0%
12.01
US$46,134 		3,841 -8.0% 12.01 US$46,134
2025-07-30 2025-07-30 S Sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
4,308 -5.9%
12.01
US$51,743 		4,308 -5.9% 12.01 US$51,743
2025-05-02 2025-05-02 PrS Proposed sale
3.0
JOHANNES VAN HOUTE

Officer

Officer
6,198
11.16
US$69,170 		6,198 11.16 US$69,170
2025-05-02 2025-05-02 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
6,198 -15.5%
11.33
US$70,243 		6,198 -15.5% 11.33 US$70,243
2025-04-30 2025-04-30 S Sale
2.9
Hansen Gwenn

Chief Scientific Officer

Officer
3,377 -5.2%
11.50
US$38,841 		3,377 -5.2% 11.50 US$38,841
2025-04-30 2025-04-30 S Sale
3.0
van Houte Hans

Chief Financial Officer

Officer
2,438 -5.8%
11.50
US$28,041 		2,438 -5.8% 11.50 US$28,041
2025-04-30 2025-04-30 S Sale
3.0
Ring Christine

Chief Legal Officer

Officer
2,894 -7.2%
11.50
US$33,286 		2,894 -7.2% 11.50 US$33,286
2025-03-03 2025-03-03 PrS Proposed sale
3.0
JOHANNES VAN HOUTE

Officer

Officer
5,825
15.45
US$89,996 		5,825 15.45 US$89,996
2025-03-03 2025-03-03 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
700 -2.0%
15.13
US$10,591 		700 -2.0% 15.13 US$10,591
2025-03-03 2025-03-03 PlS Planned sale
3.0
van Houte Hans

Chief Financial Officer

Officer
5,125 -13.0%
14.40
US$73,797 		5,125 -13.0% 14.40 US$73,797
2025-02-03 2025-01-31 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
100 -0.3%
20.48
US$2,048 		100 -0.3% 20.48 US$2,048
2025-02-03 2025-01-31 PlS Planned sale
3.0
Ring Christine

Chief Legal Officer

Officer
5,660 -14.8%
19.94
US$112,886 		5,660 -14.8% 19.94 US$112,886
Explore more

More insider trading research around Nurix Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America